Welcome to our dedicated page for BXP news (Ticker: BXP), a resource for investors and traders seeking the latest updates and insights on BXP stock.
BXP, Inc. operates as a fully integrated real estate investment trust that develops, owns, and manages premier workplaces in Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. Company news commonly covers leasing volume, occupancy, client expansions, development and redevelopment projects, strategic asset sales, acquisitions, and portfolio repositioning across urban gateway markets.
Updates also include quarterly operating results, FFO and EPS guidance, dividend declarations, distribution tax treatment, capital allocation priorities, and conference presentations addressing the office operating environment, investment activity, and balance sheet strategy.
Boston Properties (NYSE: BXP), the largest publicly traded developer and manager of Class A office properties in the U.S., will release its financial results for Q4 and full year 2021 on January 25, 2022, post-market close. A conference call is scheduled for January 26, 2022, at 10:00 A.M. ET, to discuss these results and provide updates. The call can be accessed domestically at (877) 796-3880, and internationally at (443) 961-9013. Further details, including a webcast, will be available on its Investor Relations page.
Summary not available.
Boston Properties (NYSE: BXP) announced a long-term 106,000 square foot Net Zero lease with Wellington Management at 140 Kendrick Street, Needham, Massachusetts. This lease represents a significant commitment to sustainability, marking it as the first Net Zero, Carbon Neutral office repositioning of its scale in Massachusetts. The move includes extensive renovations, such as advanced HVAC systems and solar energy generation. Wellington Management aims for carbon neutrality in its operations by the end of 2022, further strengthening their partnership with BXP.
Boston Properties (NYSE: BXP) announced a quarterly cash dividend of $0.98 per share for the period of October 1, 2021 to December 31, 2021. The dividend is payable on January 28, 2022 to shareholders on record as of December 31, 2021. As the largest publicly traded developer, owner, and manager of Class A office properties in the U.S., Boston Properties holds a portfolio of 52.5 million square feet across 202 properties, including nine under construction, as of September 30, 2021.
Boston Properties (NYSE: BXP) announced the acquisition of 360 Park Avenue South for approximately $300 million. The transaction involves assuming $200.3 million in mortgage debt and issuing 866,503 common units. The property will undergo redevelopment to cater to tech and creative sectors, enhancing its appeal in the Midtown South submarket of Manhattan. BXP now holds a 42% interest in a joint venture for the property, aiming to strengthen its market position.
Läderach-chocolatier suisse has opened a new premium chocolate store at the Prudential Center in Boston, enhancing the holiday shopping experience. This store features over 85 varieties of handcrafted chocolates, including the iconic FrischSchoggi™ chocolate bark. It marks Läderach's third store opening in Massachusetts since September 2021 and the 33rd in North America since its expansion began in November 2019. The opening is part of Läderach's ongoing commitment to providing sustainable, fresh chocolate sourced directly from Switzerland, with plans for further retail expansion in 2022.
Summary not available.
Boston Properties (NYSE: BXP) has announced a significant lease agreement for its 751 Gateway project in South San Francisco. A leading biotech company will occupy the entire 229,000 square foot space, which is under construction and expected to be ready for occupancy in early 2024. This project marks the first phase of a larger life sciences campus at Gateway Commons, in collaboration with Alexandria Real Estate Equities. Boston Properties holds a 49% stake in the venture, which is strategically located near key transportation and amenities for the life sciences sector.
BXP Life Sciences has announced the leasing of 166,000 square feet at its life sciences conversion project located at 880 Winter Street, Waltham, Massachusetts. This project, approximately 70% pre-leased, is expected to be completed in the second half of 2022. The new tenants include TScan Therapeutics, RVAC Medicines, and EdiGene, highlighting the project's appeal to life sciences organizations. BXP continues to develop its portfolio, with over 3 million square feet focused on life sciences across various markets.
Summary not available.